Nov 13, 2025 | Cancer Center News
A naturally occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a preclinical drug known as ErSO, researchers...
Oct 21, 2025 | Cancer Center News
Immunotherapy has been one of the most promising advancements in cancer treatment, however, consistency in immunotherapy treatment effectiveness remains a formidable challenge. Now, Cancer Center at Illinois member Kun Wang, Binbin Wang, a post-doctoral researcher at...
Aug 27, 2025 | Cancer Center News
Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA cancer vaccine platform. Wang’s study introduces an immune cell homing hydrogel-based platform designed to overcome one of the biggest hurdles in conventional mRNA cancer...
Aug 7, 2025 | Cancer Center News
Cancer Center at Illinois (CCIL) member Hua Wang (right) and lab member Yusheng Liu Cancer Center at Illinois (CCIL) member Hua Wang perfectly encapsulates the CCIL’s multidisciplinary approach to fighting cancer: combining engineering, biology, and interdisciplinary...
Jun 9, 2025 | Cancer Center News
Cancer Center at Illinois (CCIL) member Lin-Feng Chen published new research reporting an important factor driving chemoresistance for patients with colorectal cancer. The research is published in the journal Oncogene. Chen’s study found that the protein BRD4—present...
May 22, 2025 | Cancer Center News
The Cancer Center at Illinois (CCIL) is proud to spotlight a project led by CCIL member Yang Liu that was awarded funding from the National Cancer Institute (NCI). The study by Liu, faculty in the Department of Bioengineering, aims to build on an understanding of how...
Dec 4, 2024 | Cancer Center News
The Cancer Center at Illinois (CCIL) recently embarked on the first year of its Breakthrough and Advanced Treatment of (BEAT) Cancer Research Initiative—a collaboration with the OSF Healthcare Cancer Institute (OSF) in Peoria, IL. This project aims to facilitate an...
Oct 16, 2024 | Cancer Center News, Honors and Awards
Read time: 3 minutesKeywords: immunotherapy, cancer vaccine, CAR T cell therapy, tumor antigens, dendritic cells, mRNA, grant The American Cancer Society (ACS) awarded Cancer Center at Illinois (CCIL) member Hua Wang a Research Scholar Grant to investigate a novel...
Sep 12, 2024 | Cancer Center News
For typical illnesses, the body’s immune system is a robust, pathogen-killing machine. It provides a general defense against harmful germs while also adapting and producing antibodies that target specific bacteria or viruses. After fighting off an infection like...
Jul 3, 2024 | Cancer Center News
CHAMPAIGN, Ill. — A new method of precisely targeting troublesome cells for death using light could unlock new understanding of and treatments for cancer and inflammatory diseases, University of Illinois Urbana-Champaign researchers report. Inflammatory cell death,...
Jun 4, 2024 | Cancer Center News
On Thursday, May 9th, cancer centers across Big Ten universities held a notable gathering. Two members of the Cancer Center at Illinois (CCIL): Timothy M. Fan and Viktor Gruev, led this month’s Big Ten Cancer Research Consortium (CRC) Grand Rounds. Viktor Gruev is a...
May 8, 2024 | Cancer Center News, Honors and Awards
Cancer Center at Illinois (CCIL) members Hua Wang and Rohit Bhargava, in collaboration with clinical partners Dr. Kanishka Sircar and Dr. Jose Karam at MD Anderson, received a four-year, $1.1 million grant from the Department of Defense (DOD) Congressional Directed...